# STRENSIQ

NDC: 25682-019
Generic name: ASFOTASE ALFA
Labeler / Manufacturer: Alexion Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20151023

FDA application: BLA125513

## Active ingredients

- ASFOTASE ALFA: 80 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25682-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25682-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3387574f-5eaa-4501-a71d-4cbfbd563031